The Leadership Team at Enterome is responsible for steering the company's strategic direction, managing its operations, and overseeing the development and clinical progress of its innovative OncoMimic technology. This team comprises key executives who ensure the alignment of Enterome's business objectives with its mission to advance breakthrough cancer immunotherapies. They handle critical decision-making processes, financial oversight, clinical trial management, and corporate governance to achieve regulatory approval and commercial success for the company's drug candidates.
View all